Handwriting Analysis in Movement Disorders.
Launched by WESTERN UNIVERSITY, CANADA · May 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how handwriting can reveal important information about movement disorders, which are conditions that affect how people move. These might include diseases like Parkinson's, dystonia, and Tourette syndrome. Researchers want to understand the differences in how people with these conditions write compared to those who don’t have movement disorders. To do this, participants will use an inkless pen on a special tablet that captures their handwriting movements. The entire process will take about 30 minutes.
To be part of this study, participants must have a diagnosed movement disorder. However, individuals with certain conditions that make it hard to write or who cannot understand English will not be eligible. This study could help improve our understanding of how movement disorders affect daily tasks like writing, which can be an important part of communication for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (1) Diagnosed with a movement disorder.
- Exclusion Criteria:
- • 1. Action tremor or weakness in the dominant hand interfering with writing task.
- • 2. Unable to write or understand English
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported